C1 esterase inhibitor [human] (C1INH-nf)
LEVP2006-1
Phase 3 mab completed
Quick answer
C1 esterase inhibitor [human] (C1INH-nf) for Hereditary Angioedema is a Phase 3 program (mab) at Takeda Pharmaceuticals International AG with 5 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Hereditary Angioedema
- Phase
- Phase 3
- Modality
- mab
- Status
- completed